Overview

GP Biosciences Ltd. is a leading edge bio-technology company with the most advanced technologies for glycan structure analysis and related applications.

Management Principles

We will contribute to human health.

History

2012/02/29

Trans Genic Inc. and GP Biosciences has agreed on the transfer of Gene Analysis Service Business from GPB to TGI.

2011/5/20

Ikkei Matsuda resigned the Director, and Jun-ichi Miura (President & CEO, Hokkaido Venture Capital) was elected instead.

2010/11/8

Eniwa R&D Center was established.

2010/8/E

With the allocation of new stocks to third parties, the total amount of investment reached 167,300,000JPY.

2009/12/22

GPB has strengthed it's domestic contract analysis services with the business transfer of PGx Research Center, Moritex Corp.

2009/11/E

With the allocation of new stocks to third parties, the total amount of investment reached 137,300,000JPY.

2009/06/E

GPB accepted investments from Hokkaido Venture Capital and Angel Capital, and thereby the total amount of investment reached 82,300,000JPY.

2009/05/01

The business of Moritex Glycomics Research Lab. has been completely transferred to GP Biosciences on this day.

2009/03/19

GP Biosciences evolved as a leading edge lectin microarray company by taking over the business rights of Glycomics Research laboratory, Moritex Corporation, which was a pioneer in glycan profling technology in Japan, and by obtaining a license of their patents from Procognia which has the HQ in Israel . Procognia Japan will be merged into GP Biosciences in March.

2009/02/27

GP Biosciences Ltd. was newly registered as a glycomics focused company.

Fundamental Information

Pamphlets	Company Profile: 148KB Products Outline: 740KB
Capital	132,800,000 JPY (April 1, 2012)
Capital Reserve	100,500,000 JPY (April 1, 2012)
Net Sales	undisclosed yet
Employees	10 (April 1, 2012)
Company Executives	President & CEO:Sueaki Takabatake Executive Director & CSO: Masao Yamada Director: Saeko Nagatomi Director (Non-executive): Yoshitaka Kataoka Director (Non-executive): Ronald Long Director (Non-executive): Jun-ichi Miura Auditor: Shinji Hiruta
Headquarters	3-2-5-406, Minami-kyujo nishi, Chuo-ku, Sapporo 064-0809, Japan TEL: +81-11-206-1456, FAX:+81-11-206-1457,
Keihin Operation Center	1-3-3 Azamino-minami, Aoba-ku, Yokohama 225-0012, Japan TEL: +81-45-913-5803, FAX: +81-45-511-8570, Access
Eniwa R&D Center	E-108, Eniwa Research Business Park, 3-1-1, Megumino-kita, Eniwa, Japan TEL: +81-123-29-3707, FAX: +81-123-29-3707,
Osaka Branch, Saito R&D Center	201 Saito Bio Incubation Center, 7-7-20, Asagi, Saito, Ibaraki, Osaka 567-0085, Japan